SCHEMBL740599

SCHEMBL740599

COc1cccc(C(=O)Nc2n[nH]c3sc(C(=O)NC(C)(C)c4ccccc4)cc23)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.49
TP53 P04637 1/20 0.45
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
ABL1 P00519 2/20 0.45
BCR P11274 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
CDK7 P50613 2/20 0.44
CDK2 P24941 2/20 0.44
CDC7 O00311 1/20 0.44
DAPK3 O43293 1/20 0.44
JAK2 O60674 1/20 0.44
ROCK2 O75116 1/20 0.44
MAP4K4 O95819 1/20 0.44
PAK4 O96013 1/20 0.44
PRKACA P17612 1/20 0.44
FLT3 P36888 1/20 0.44
CSNK1A1 P48729 1/20 0.44
CLK2 P49760 1/20 0.44
GSK3A P49840 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL741609 0.91 AURKA (0.52) AURKATP53NPC1RAB9AABL1
SCHEMBL740292 0.90 AURKA (0.55) AURKANPC1RAB9AABL1BCR
SCHEMBL742124 0.87 AURKA (0.48) AURKATP53NPC1RAB9AABL1
SCHEMBL739779 0.87 AURKA (0.52) AURKANPC1RAB9AABL1BCR
SCHEMBL4632762 0.86 SMN1; SMN2 (0.51) TP53NPC1RAB9ASMN1; SMN2CDK7
SCHEMBL1779927 0.85 RXFP1 (0.49) AURKANPC1RAB9AABL1BCR
SCHEMBL739893 0.84 RAB9A (0.48) AURKATP53NPC1RAB9AABL1
SCHEMBL740809 0.84 AURKA (0.52) AURKAABL1BCRCDK7CDK2
SCHEMBL740955 0.84 CDK7 (0.48) AURKAABL1BCRSMN1; SMN2CDK7
SCHEMBL742320 0.84 AURKA (0.44) AURKANPC1RAB9AABL1BCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed